A M Walker

3.3k total citations
60 papers, 2.5k citations indexed

About

A M Walker is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, A M Walker has authored 60 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 6 papers in Infectious Diseases and 6 papers in Molecular Biology. Recurrent topics in A M Walker's work include Hepatitis C virus research (4 papers), HIV, Drug Use, Sexual Risk (4 papers) and Environmental Justice and Health Disparities (4 papers). A M Walker is often cited by papers focused on Hepatitis C virus research (4 papers), HIV, Drug Use, Sexual Risk (4 papers) and Environmental Justice and Health Disparities (4 papers). A M Walker collaborates with scholars based in United States, United Kingdom and Australia. A M Walker's co-authors include Stephen H. Gehlbach, María Heimisdóttir, J. Robert Kirkwood, Carol Bigelow, Susanne May, W. Douglass Shaw, D. N. Hutchinson, B. Rowe, C Newman and D R Morgan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and JNCI Journal of the National Cancer Institute.

In The Last Decade

A M Walker

58 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A M Walker United States 22 595 454 344 293 263 60 2.5k
Aaron M. Wendelboe United States 23 1.6k 2.6× 649 1.4× 1.0k 3.0× 86 0.3× 407 1.5× 60 4.5k
Anthony J. Schaeffer United States 33 2.0k 3.3× 800 1.8× 144 0.4× 99 0.3× 130 0.5× 152 5.0k
G. Neale United Kingdom 35 665 1.1× 880 1.9× 42 0.1× 297 1.0× 238 0.9× 136 4.1k
Richard M. Shepard United States 18 526 0.9× 87 0.2× 133 0.4× 213 0.7× 234 0.9× 28 2.0k
John A. Papadakis Greece 28 388 0.7× 759 1.7× 77 0.2× 68 0.2× 94 0.4× 111 2.4k
Renu Gupta India 21 245 0.4× 171 0.4× 32 0.1× 88 0.3× 213 0.8× 100 1.5k
Jaana Syrjänen Finland 32 1.1k 1.9× 504 1.1× 119 0.3× 162 0.6× 839 3.2× 98 3.8k
Jieming Qu China 29 587 1.0× 395 0.9× 73 0.2× 300 1.0× 842 3.2× 116 4.0k
Mochammad Hatta Indonesia 29 848 1.4× 421 0.9× 109 0.3× 90 0.3× 1.1k 4.2× 323 3.2k
Robert C. Tait United Kingdom 50 621 1.0× 1.1k 2.4× 102 0.3× 206 0.7× 120 0.5× 168 8.7k

Countries citing papers authored by A M Walker

Since Specialization
Citations

This map shows the geographic impact of A M Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A M Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A M Walker more than expected).

Fields of papers citing papers by A M Walker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A M Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A M Walker. The network helps show where A M Walker may publish in the future.

Co-authorship network of co-authors of A M Walker

This figure shows the co-authorship network connecting the top 25 collaborators of A M Walker. A scholar is included among the top collaborators of A M Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A M Walker. A M Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walker, A M. (2018). The last days of smallpox: tragedy in Birmingham. Journal of Hospital Infection. 100(4). 478–478.
2.
Mallett, Andrew J., Dylan Mordaunt, A M Walker, et al.. (2015). Rmnd1 Mutations Are Associated with Autosomal Recessive Syndromic Nephropathy. Nephrology. 20. 42–42. 1 indexed citations
3.
Craine, Noel, Matthew Hickman, Jane Parry, et al.. (2009). Incidence of hepatitis C in drug injectors: the role of homelessness, opiate substitution treatment, equipment sharing, and community size. Epidemiology and Infection. 137(9). 1255–1265. 65 indexed citations
4.
Jakus, Paul M., et al.. (2009). Risk perceptions of arsenic in tap water and consumption of bottled water. Water Resources Research. 45(5). 75 indexed citations
5.
Carnicer-Pont, Dolors, et al.. (2006). Risk factors for hospital-acquired methicillin-resistant Staphylococcus aureus bacteraemia: a case-control study. Epidemiology and Infection. 134(6). 1167–1173. 42 indexed citations
6.
Kharasch, Evan D., et al.. (2004). Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: Noninvasive assessment by use of pupillary miosis. Clinical Pharmacology & Therapeutics. 76(5). 452–466. 104 indexed citations
7.
Detmer, Kristina, et al.. (2004). Hedgehog signaling and cell cycle control in differentiating erythroid progenitors. Blood Cells Molecules and Diseases. 34(1). 60–70. 13 indexed citations
8.
Craine, Noel, A M Walker, Susanna Williamson, Allen W. Brown, & Vivian Hope. (2004). Hepatitis B and hepatitis C seroprevalence and risk behaviour among community-recruited drug injectors in North West Wales.. LSHTM Research Online (London School of Hygiene and Tropical Medicine). 14 indexed citations
9.
Petrović, Marko D., Richard J. Roberts, A M Walker, et al.. (2003). Vero Cytotoxin–ProducingEscherichia coliO157 Gastroenteritis in Farm Visitors, North Wales. Emerging infectious diseases. 9(5). 526–530. 29 indexed citations
10.
Hughes, Alan, et al.. (2000). Anticholinesterases in the treatment of Alzheimer's dementia--the first year's experience in Argyll & Clyde.. PubMed. 58(1). 20–4. 1 indexed citations
11.
Gehlbach, Stephen H., Carol Bigelow, María Heimisdóttir, et al.. (2000). Recognition of Vertebral Fracture in a Clinical Setting. Osteoporosis International. 11(7). 577–582. 308 indexed citations
12.
Al-Jader, Layla N., et al.. (1999). Outbreak of Escherichia coli O157 in a nursery: lessons for prevention. Archives of Disease in Childhood. 81(1). 60–63. 34 indexed citations
13.
Menniti‐Ippolito, Francesca, et al.. (1998). Ketorolac use in outpatients and gastrointestinal hospitalization: a comparison with other non-steroidal anti-inflammatory drugs in Italy. European Journal of Clinical Pharmacology. 54(5). 393–397. 30 indexed citations
14.
Walker, A M, et al.. (1997). 5-Aminosalicylates, sulfasalazine, steroid use, and complications in patients with ulcerative colitis.. PubMed. 92(5). 816–20. 31 indexed citations
15.
Zatoński, Witold, Albert B. Lowenfels, Peter Boyle, et al.. (1997). Epidemiologic Aspects of Gallbladder Cancer: A Case-Control Study of the SEARCH Program of the International Agency for Research on Cancer. JNCI Journal of the National Cancer Institute. 89(15). 1132–1138. 210 indexed citations
16.
Walker, A M. (1995). The infrequency of liver function testing in patients using nonsteroidal anti-inflammatory drugs. Archives of Family Medicine. 4(1). 24–29. 13 indexed citations
17.
18.
Wheeler, A. G., A M Walker, & Jenny M. Lean. (1987). Influence of adrenergic receptors on ovarian progesterone secretion in the pseudopregnant cat and oestradiol secretion in the oestrous cat. Reproduction. 79(1). 195–205. 10 indexed citations
19.
Foster, Gary, H. Panigrahi, & A M Walker. (1986). Failure of chemoprophylaxis to prevent meningococcal disease.. BMJ. 292(6524). 886–887. 9 indexed citations
20.
Walker, A M, et al.. (1982). No Seasonality in the Diagnosis of Acute Leukemia in the United States<xref ref-type="fn" rid="FN2">2</xref>. JNCI Journal of the National Cancer Institute. 69(6). 1283–7. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aaron M. Wendelboe Breakdown of academic impact, for papers by Anthony J. Schaeffer Breakdown of academic impact, for papers by G. Neale Breakdown of academic impact, for papers by Richard M. Shepard Breakdown of academic impact, for papers by John A. Papadakis Breakdown of academic impact, for papers by Renu Gupta Breakdown of academic impact, for papers by Jaana Syrjänen Breakdown of academic impact, for papers by Jieming Qu Breakdown of academic impact, for papers by Mochammad Hatta Breakdown of academic impact, for papers by Robert C. Tait
Rankless by CCL
2026